Sitemap

December 20, 2022 Articles

Filter by Available Specialty
  1. 2022 in review: Pediatricians answer questions about polio, mpox, COVID-19 vaccines
  2. ACC announces late-breaking science lineup for 2023 Scientific Session
  3. Addressing depression may improve outcomes in psoriatic arthritis
  4. Antimicrobial photodynamic therapy may treat nasal carriage of S. aureus
  5. Artificially sweetened beverages do not increase women’s odds of urinary incontinence
  6. BLOG: Organizations partner to expand access to bone marrow transplant, cell therapy
  7. Cancer history does not affect survival odds for adults with anaplastic thyroid carcinoma
  8. Cement augmentation may yield cost savings, QALY gains in unstable trochanteric fractures
  9. Congress unveils bipartisan bill that would extend telehealth flexibilities for 2 years
  10. Declines in opioid prescriptions outpace increases in nonopioids for cancer, noncancer pain
  11. Developing tolerance for baked eggs may improve quality of life in kids with egg allergy
  12. Ergonomics in ophthalmology a lifelong project
  13. European Commission approves Dupixent, first targeted treatment for prurigo nodularis
  14. Exercise, mindfulness training do not seem to impact cognition in older adults
  15. FDA lifts partial clinical hold on studies of gene therapy for sickle cell disease
  16. Future research needed to investigate link between plant-based food intake, CRC
  17. Highlights from ASH 2022
  18. Hoping for a biosimilar ‘sea change’: Rheumatologists weigh 2023 end of Humira exclusivity
  19. Increased prediabetes, undiagnosed diabetes in premenopausal women in past 2 decades
  20. Iveric Bio submits final part of Zimura new drug application for rolling review
  21. Jobs with highest COPD mortality include mining, food services, construction
  22. Male providers more likely to prescribe biologic immune modifiers, oral small molecules
  23. Medically serious suicide attempts in ICU similar to those who take their own lives
  24. Mucosal vaccines for COVID-19 ‘should be developed and tested’
  25. Omalizumab boosts time to clinically meaningful response in chronic spontaneous urticaria
  26. Osteoporosis prevalence remains high in patients with rheumatoid arthritis
  27. Patients with AUD demonstrate engagement, abstinence in digital therapeutic treatment
  28. Patients with gout may be at higher risk for severe COVID-19 even after vaccination
  29. Phentolamine improved distance-corrected near visual acuity
  30. Presenter: THA femoral periprosthetic fractures difficult, but not impossible to manage
  31. Prolonged cold ischemia time may not be reason to discard kidney donations
  32. Q&A: Genetic-based screening may provide insight into rare forms of epilepsy
  33. Q&A: How a gut-derived metabolite may predict incidence, severity of HF
  34. Q&A: What is stiff-person syndrome?
  35. Reducing pulmonary capillary wedge pressure may not improve exercise capacity in HFpEF
  36. Study of CAR-T for patients with non-Hodgkin lymphoma, HIV yields 'reassuring' results
  37. The anatomy of a meeting: Reflections on #ACR22
  38. Tom Frinzi to become CEO of STAAR Surgical
  39. Top in ID: Free at-home COVID-19 tests; malaria prevalence
  40. VA’s interprofessional training program improves quality of primary care
  41. Vaping-associated lung injury tied to long-term respiratory disability, mood disorders
  42. VIDEO: CAR T-cell access lags for those with relapsed refractory multiple myeloma
  43. VIDEO: Daunorubicin 60 mg/m2 may be favored in AML induction therapy dose debate
  44. VIDEO: Melphalan dosing, immunotherapy considered in multiple myeloma research
  45. VIDEO: Momelotinib benefits maintained at 24 weeks in patients with anemic myelofibrosis
  46. VIDEO: New CAR-T targets show activity
  47. VIDEO: New data on paclitaxel plus trastuzumab in early HER2-positive breast cancer
  48. VIDEO: Physicians should rely on clinical expertise as foundation for social media presence
  49. VIDEO: Remission rates comparable with shorter venetoclax regimen in AML
  50. VIDEO: Sacituzumab govitecan effective regardless of Trop-2 expression level
  51. VIDEO: Studies on early-relapse multiple myeloma treatment highlighted at ASH